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Abstract
Background: Anemia is a common manifestation found 
among patients with Systemic Lupus Erythematosus 
(SLE). It may be caused by iron-deficiency, autoimmune 
hemolytic, and chronic inflammation. Each anemia has 
different therapy approachments. Without adequate 
management, anemia may lead to poor prognosis. 
By identifying the etiology of anemia, appropriate 
management could be conducted. Reticulocyte 
Hemoglobin Equivalent (RET-He) and reticulocyte count 
test may distinguish anemia based on its etiology. This 
study aimed to give scientific portrayed of the proportion 
of anemia based on its etiology among patients with SLE 
using RET-He and reticulocyte count. 
Method: This study involved women diagnosed with SLE 
underwent outpatient treatment in Rheumatology Clinic, 
Dr. Hasan Sadikin General Hospital during September-
October 2016. Data were collected from blood exam 
using 35-parameters hematology Sysmex by calculating 
levels of hemoglobin, RET-He, and reticulocyte count. 
Results: Seventy four female patients were volunteered 
as subject in this study with median of age was 29.5 
(16-70) years old. Thirty four (46%) of 74 subjects were 
suffering from anemia and 12 (35%) of them were 
between 25-34 years old. Proportion of iron-deficiency 
anemia, autoimmune hemolytic anemia, and chronic 
inflammatory anemia were 14 ( 41%), 13 (38%), and 7 
(21%), respectively.
Conclusion: Based on hemoglobin, RET-He, and 
reticulocyte count, iron-deficiency anemia is the most 
common anemia among patients with SLE in repoductive 
age.
Keyword: Age, Anemia, Reticulocyte, RET-He, Systemic 
Lupus Erythematosus (SLE)
Introduction
Anemia is the most common hematology 
complication among Systemic Lupus Erythematosus 
(SLE) patients, with prevalence of 59%.1 This 
complication may raise morbidity and mortality of 
SLE patients It will reduce patient’s life quality, if it 
is not treated appropriately.2 Renal failure, serositis, 
and seizure are several complication presented in 
that circumstances.3 It rise the urgency to detect 
the etiology of anemia among SLE patients. So 
appropriate treatment would be given according to 
etiology. 
Etiology of anemia among SLE patients may 
vary such as iron deficiency, autoimmune hemolytic, 
and chronic inflammatory.4iron deficiency anaemia 
(IDA Each anemia has different approach to treat. 
Previous study stated that anemia among SLE 
were commonly found on particular age range of 
15-29 years old,5 thus approach of anemia etiology 
according to age may assist in managing therapy.
The requirement of iron among reproductive-
aged women is also risen due to menstruation 
and preparation for pregnancy.  Pregnant women 
suffered from anemia have higher level of morbidity 
and mortality6. Besides, anemia will also affect fetal 
development.7 Therefore, early detection of anemia 
among reproductive-aged women is important.
In 2005 similar study to portray proportion of 
each anemia in patients with SLE was conducted 
using ferritin as the parameter. Ferritin level 
in patient with SLE is likely to increase due to 
inflammation.8 Therefore, the study revealed bias 
results. Method to detect etiology of anemia by 
measuring level of hemoglobin in reticulocyte 
(RET-He) is suggested to be more efficient and 
cheaper.9 This parameter easily distinguish iron-
deficiency anemia accurately with a sensitivity of 
93.3% and a specificity of 83.2%.9 On the other 
side, reticulocyte count may be used as reference 
to differentiate autoimmune hemolytic anemia,10 
thus by combining both parameters, the etiology of 
anemia among SLE patients may be identified. 
In this study, we applied combination of 
hemoglobin level measurement, RET-He, and 
reticulocyte count among SLE patients, and try to 
find each proportion anemia based on its etiology.
Method
This descriptive study with cross-sectional design 
and consecutive sampling method had been done 
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to 74 women diagnosed with SLE visited Rheumatology 
Clinic, Dr. Hasan Sadikin General Hospital Bandung during 
September to October 2016. This study had been approved 
by hospital ethical committee of Dr. Hasan Sadikin General 
Hospital.
Systemic Lupus Erythematosus patients with ongoing 
bleeding include menstruation period or infection and SLE 
patients who had received packed red cell blood transfusion in 
the prior three months were excluded from this study. Blood 
samples were taken at laboratory of Clinical Pathology Dr. 
Hasan Sadikin General Hospital with patient’s consent. Blood 
test included hemoglobin level, RET-He level, and reticulocyte 
count, were performed using Sysmex XN 1000. The machine 
uses principles of flow cytometry, where blood sample will 
be converted into a fluorescent-labeled suspension and then 
inserted into a narrow gap, and was shot by some rays.11
Patients were classified as anemia if hemoglobin level 
was <12gr/dL. For etiology classification, we referred to 
RET-He level and reticulocyte count. RET-He level <27.2 pg 
showed iron deficiency anemia and reticulocyte count >1.5% 
showed autoimmune hemolytic anemia, while in chronic 
inflammatory anemia RET-He level ≥27.2 pg and reticulocyte 
count ≤1.5%.9,10  Results in this study were processed by using 
software in the computer. 
Table 1. Classification of Anemia
Type of Anemia RET-He Reticulocyte Count 
Iron Deficiency Anemia <27.2 pg ≤1.5%
Chronic Inflammatory Anemia ≥27.2 pg ≤1.5%
Autoimmune Hemolytic Anemia ≥27.2 pg >1.5%
Results
SLE patients most commonly found between 25-34 years 
old. Thirty four (46%) of 74 subjects were suffered anemia. 
Subjects’ age were not well-distributed, and it was known 
that the median was 29.5 (16-70) years old. Characteristic of 
subjects were presented in table 2.
Table 2. Characteristic of Subjects 
 Variable Result
Hemoglobin (g/dL) 12.15 (6-16)*
Age (years old) 29.5 (16-70)*
15-24, N(%) 19 (26%)
25-34, N(%) 29 (39%)
35-44, N(%) 17 (23%)
45-54, N(%) 8 (11%)
55-64, N(%) 0 (0%)
65-74, N(%) 1 (1%)
Patients with anemia, N(%) 34 (46%)
   Hemoglobin (g/dL) 9.95 (5.6-11.5)*
   RET-He  (pg) 26.98 ± 5.37
   Jumlah Retikulosit (%) 1.86 (0.34-11.25)
*:Not normally distributed data
There were 3 subjects with RET-He < 27.2 pg and 
reticulocyte count >1.5% which were included into iron 
deficiency anemia cases. Proportion of Anemia based on 
its etiology and the results of the blood tests in non-anemic 
subjects were presented in table 3.
Table 3. Proportion of Anemic and Non-Anemic SLE Patients 
 
Iron 
deficiency anemia
(14 patients, 19% *)
Autoimmune
hemolytic anemia
(13 patients, 18%)
Chronic
inflammatory anemia 
(7 patients, 9%)
No anemia
(40 patients, 54%)
Hb (g/dL) 9.95 (5.7 - 11.7) 9.78 ± 1.57 9.29 ± 1.95 13 (12 - 15.8)
RET-he (pg) 21.74 ± 3.24 31.69 ± 3.10 28.71 ± 1.16 31.2 (24.9 - 38)
Reticulocyte count (%) 1.88 (0.34 - 11.25) 2.02 (1.51 - 10.58) 0.91 ± 0.33 1.68 ± 0.51
Age (years old) 32.86 ± 10.79 28.85 ± 9.48 28.29 ± 8.42 31 (16-70)
15-24 4(28%) 4 (31%) 3(44%) 8 (20%)
25-34 4(28%) 6(46%) 2(28%) 17 (43%)
35-44 3(22%) 3(23%) 2(28%) 9 (22%)
45-54 3(22%) 0 0 5 (12%)
55-64 0 0 0 0
65-74 0 0 0 1(3)
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Discussion 
Proportion of anemia in this study was not different from 
previous study in Dr. Hasan Sadikin General Hospital 
Bandung in 2005, stated that proportion of anemia in SLE 
patients was 48%.12 It is also in line with study stated that 
SLE patients had suffered from  hematology disorder, 50% 
of them were anemia.13 Proportion of each anemia in this 
study were different with last study in Dr. Hasan Sadikin 
General Hospital Bandung on 2005, in which there were 
no iron deficiency anemia, 8% of autoimmune hemolysis 
anemia, and 92% of chronic inflammatory anemia.12 The 
differences may be caused by different parameter used. In 
previous study, parameter ferritin were used to portray iron 
reserved in the body. Unfortunately this parameter is likely to 
increase in patient with SLE with inflammation so it tends to 
be misdiagnosed of chronic inflammatory anemia. Therefore 
in this study, more recent parameters, which are RET-He and 
reticulocyte count were used.
RET-He or Reticulocyte Hemoglobin Equivalent is 
a parameter calculating means of hemoglobin level in 
reticulocyte. It capables to detect iron availability used in 
erythropoiesis process. Normal limit for RET-He is 27.2 
pg, means the amount of iron is available for performing 
erythropoesis, with sensitivity 93.3% and specificity 83.2%.9
Erythropoiesis process starts from pronormoblast, 
basophilic normoblast, polychromatophlic normoblast, 
orthochromatophylic normoblast, reticulocyte, and 
erythrocyte. During the basophilic normoblast phase, 
hemoglobin formation is initiated and the process requires 
iron continuously.10 The process of hemoglobin formation 
is starting from reticulocyte phase and stop when red blood 
cells have became matured erythrocytes.10 In case when 
iron availability is depleted, hemoglobin formation process 
will disturb. This will lead the lack of hemoglobin level in 
immature red blood cells.9 Therefore in iron deficiency anemia 
the RET-He level is decreased.
Level of RET-He among patients with anemia was lowest 
on patient aged between 45-54 years old, because subjects 
are not been in reproductive period anymore. Low iron level 
during menopause is usually caused by iron malabsorption 
and chronic gastrointestinal bleeding.14 
In the study conducted in 2014, RET-He was used as 
parameter to evaluate anemia in patients with cancer and it 
was concluded that 32 pg was a cut-off point to eliminate 
iron deficiency with negative predictive value of 98.5% and 
100%.15 Other study in 2013 also used RET-He as a parameter 
to analyze iron deficiency in geriatric patients and it was 
concluded that cut off value of 26 pg was able to distinguished 
iron deficiency anemia with chronic inflammatory anemia 
with sensitivity of 85% and specificity of 69%.16
Level of reticulocyte in iron deficiency anemia might be 
normal, which is ranged between 0.5-1.5%.10 In several subjects 
with low RET-He level and reticulocyte of >1.5% and in non-
anemic patients the median of reticulocyte count was high, it 
might be cause by iron supplementation. Iron supplementation 
therapy will raise reticulocyte count quickly.17 
In patients with autoimmune hemolytic anemia, level of 
RET-He are expectedly to be normal since no iron absorption 
disturbance happened during erythropoiesis. In autoimmune 
hemolytic anemia, antibody is not able to distinguish external 
and self-antigen, thus antibody attacks erythrocyte antigen.10 
The destruction of erythrocyte is compensated by the rise of 
erythropoiesis, marked by the raise of reticulocyte count.10  
Chronic inflammatory anemia is caused by a long-term 
cytokine production. Cytokine IL-1, IL-6, tumor necrosis 
factor-α (TNF-α), and interferon-gamma (IFN-γ) lead to 
the reduction of eryhtrocyte age, disturbance on erythroid 
progenitor cell proliferation, and rising of cellular iron uptake 
and retention.18 Increasing cytokines will raise hepcidin, 
thus reduces intestinal iron absorption.18 IL-1 also activates 
macrophages, leading to the rise of serum iron uptake and iron 
reserve, but IL-6 affects negatively in iron reserve release to 
the blood.19 The reduction of erythropoiesis process caused 
stagnant or even reduced reticulocyte count in patients with 
chronic inflammatory anemia in this study. Level of RET-He 
in patients with chronic inflammatory anemia in this study also 
tended to be normal since iron reserve for erythropoiesis was 
not depleted. According to study conducted in 2011 among 
patients with rheumatoid arthritis, it was known that RET-
He level among patients with chronic inflammatory anemia 
were significantly higher compared with patients with iron-
deficiency anemia.19 
This study revealed that majority SLE patients were 
reproductive-aged woman and most of them were suffering 
anemia. Most common type of anemia found was iron-
deficiency anemia, followed by autoimmune hemolytic 
anemia and chronic inflammatory anemia. Most patients 
suffered from anemia were between 25-34 years old. 
General characteristic seen in this study only revealed 
anemia in women since overall subjects were exclusive to 
women. Median age of participants was 29.5 years old, a 
reproductive age. This result was consistent to previous study 
stated that SLE was commonly found among reproductive-
aged women.20 It might be influenced by high estrogen 
hormones level among reproductive aged women, leading into 
the raise of immune responses.21 
Most patients with anemia and patients with lowest 
hemoglobin level were aged between 25-34 years old. Anemia 
on SLE patients in reproductive age may be caused by the 
SLE itself, or other additional factors such as menstruation, 
high parity, or low socioeconomic level.22,23
Reproductive-aged women needs more iron intake due 
to menstrual bleeding and preparation of pregnancy. Women 
experience the rise of blood volume during pregnancy, 
around 40-45%, in order to fulfill the needs of angiogenesis 
in enlarging uterus, the needs of fetal and maternal if venous 
return disturbance were occurred, and to reserve blood 
if bleeding was happened during the parturition.24 Iron is 
vital for fetal brain development especially during the first 
trimester. Iron deficiency anemia during pregnancy may lead 
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into mental growth retardation of the children 7 Iron deficiency 
anemia during pregnancy also raise the risk of preterm birth.25 
Moreover, pregnancy on SLE patients may raise the disease 
activity.26 Anemia in SLE patients during pregnancy may 
cause by the progression of disease. However, distinguish it 
with anemia in normal women during pregnancy is difficult.27 
The rise of disease activity may threat maternal and fetal safety 
which lead to an abortion.20,28 Thus finding the etiology of each 
anemia is important, so anemia can be treated appropriately.
Lacking of samples limited this study. Minimal samples 
with 95% interval confidence was 96 patients, while in this 
study, only 74 patients participated as research subjects, 90% 
of predicted samples. Other limitation was inability to detect 
the mixed of chronic inflammatory anemia and iron-deficiency 
anemia since RET-He parameter was weak to distinguished 
both type of anemia.28 We did not record the socioeconomic 
level, parity and other causes of anemia, so we could not 
concluded any the other factors causing anemia in this study.
We suggest to perform further study with higher number of 
subjects thus the portray of SLE patients will be more accurate. 
The use of other parameter such as ferritin, inflammation test, 
and better therapy documentation given to the patients will 
also enhance the more accurate results.
Conclusion
It is concluded that almost half of patients with SLE in Dr. 
Hasan Sadikin General Hospital Bandung year of 2016 
was suffering from anemia. Anemia in SLE was more 
commonly found among patients aged between 25-34 years 
old. According to the parameter of RET-He and reticulocyte 
count, iron deficiency anemia is the most common type of 
anemia found, followed by autoimmune hemolytic anemia 
and chronic inflammatory anemia. Parameter of RET-He may 
not able to distinguish etiology of anemia on SLE patients by 
itself, and needs the addition of other parameters. 
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